Posted inDiabetes Drugs (Pharmaceuticals) Eli Lilly and Company Insulin Eli Lilly Says It Will Cut the Price of Insulin The company said it would cap the monthly out-of-pocket cost of the diabetes drug at $35. Posted by By Christine Hauser
Posted inDrugs (Pharmaceuticals) Inventions and Patents Jazz Pharmaceuticals Inc A Drug Company Exploited a Safety Requirement to Make Money With a history as a date rape drug, a medication needed strict distribution controls. Its maker, Jazz Pharmaceuticals, used that to delay competition. Posted by By Rebecca Robbins
Posted inDrugs (Pharmaceuticals) Food and Drug Administration States (US) Suits and Litigation (Civil) 12 States Sue F.D.A., Seeking Removal of Special Restrictions on Abortion Pill The suit argues that rules applying to mifepristone unnecessarily limit patients’ access to medication abortion. Posted by By Pam Belluck
Posted inDrug Abuse and Traffic Drugs (Pharmaceuticals) Drugstores Emergent BioSolutions Inc Food and Drug Administration Naloxone (Drug) Opioids and Opiates United States Politics and Government Narcan Is Safe to Sell Over the Counter, Advisers to the FDA Conclude The overdose reversal drug has been administered mostly by emergency responders and outreach workers. If the agency approves a nonprescription version, it could become as easily available as aspirin. Posted by By Jan Hoffman